Evidence map›Paper›PMID 37111286›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Bioactivity of

Amal Feki, Intissar Kammoun, Malek Eleroui, Rim Kallel, Fatma Megdiche, Liwa Hariz, Tahia Boudawara, Choumous Kallel, Hatem Kallel, Jean Marc Pujo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Acute toxic effects ofToxicon: X · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Amal FekiLaboratory of Medicinal and Environment Chemistry, University of Sfax, Higher Institute of Biotechnology, Sfax 3000, Tunisia.ORCID 0000-0003-1469-5969
Intissar KammounLaboratory of Medicinal and Environment Chemistry, University of Sfax, Higher Institute of Biotechnology, Sfax 3000, Tunisia.
Malek ElerouiLaboratory of Medicinal and Environment Chemistry, University of Sfax, Higher Institute of Biotechnology, Sfax 3000, Tunisia.
Rim KallelLaboratory of Anatomopathology, CHU Habib Bourguiba, University of Sfax, Sfax 3029, Tunisia.
Fatma MegdicheLaboratory of Hematology, CHU Habib Bourguiba, University of Sfax, Sfax 3029, Tunisia.
Liwa HarizLaboratory of Anatomy, Faculty of Medicine of Sfax, Department of Orthopedic and Traumatological Surgery, CHU Habib Bourguiba, Sfax 3029, Tunisia.
Tahia BoudawaraLaboratory of Anatomopathology, CHU Habib Bourguiba, University of Sfax, Sfax 3029, Tunisia.
Choumous KallelLaboratory of Hematology, CHU Habib Bourguiba, University of Sfax, Sfax 3029, Tunisia.
Hatem KallelIntensive Care Unit, Cayenne General Hospital, Cayenne 97300, French Guiana.
Jean Marc PujoTropical Biome and Immunopathology CNRS UMR-9017, Inserm U 1019, University of Guyane, Cayenne 97300, French Guiana.
Ibtissem Ben AmaraLaboratory of Medicinal and Environment Chemistry, University of Sfax, Higher Institute of Biotechnology, Sfax 3000, Tunisia.
University of Sfax · TNUniversity of French Guiana · GFHopital Universitaire Habib Bourguiba · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the potentiality of a mineral and antioxidant-rich methanolic extract of the red marine alga

Indexed as

DNA degradationFalkenbergia rufolanosagenotoxicityMethyl-thiophanatemineral compositionoxidative stress

Identifiers

PMID37111286
PMCPMC10145447
OpenAlexW4362591511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.